CORC

浏览/检索结果: 共5条,第1-5条 帮助

限定条件                    
已选(0)清除 条数/页:   排序方式:
A Phase IIIb Trial of Afatinib in EGFRm plus NSCLC: Analyses of Outcomes in Patients with Brain Metastases or Dose Reductions 会议论文
作者:  Wu, Y.;  Tu, H.;  Feng, J.;  Shi, M.;  Zhao, J.
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/05
A phase III trial of muparfostat (PI-88) as adjuvant therapy in patients with hepatitis virus related hepatocellular carcinoma (HV-HCC) after resection 会议论文
作者:  Chen, P-J.;  Lee, P-H.;  Han, K-H.;  Fan, J.;  Cheung, T. T.
收藏  |  浏览/下载:6/0  |  提交时间:2019/12/05
A Phase IIIb Open-Label, Single-Arm Study of Afatinib in EGFR TKI-Naive Patients with EGFRm plus NSCLC: An Interim Analysis 会议论文
作者:  Wu, Y.;  Tu, H.;  Feng, J.;  Shi, M.;  Zhao, J.
收藏  |  浏览/下载:6/0  |  提交时间:2019/12/05
afatinib  EGFR  NSCLC  
Study in Asia of the combination of transcatheter arterial chemoembolization (TACE) with sorafenib in patients with hepatocellular eareino (HCC) trial (START); Second interim safety and efficacy analysis 会议论文
作者:  Chung, Y.;  Kim, B.;  Chen, C.;  Wang, J.;  Chu, H.
收藏  |  浏览/下载:1/0  |  提交时间:2019/12/19
IRON CHELATION THERAPY WITH DEFERASIROX FOR TRANSFUSIONAL IRON-OVERLOADED PATIENTS WITH APLASTIC ANAEMIA AND OTHER RARE ANAEMIAS 会议论文
作者:  Porter, J. B.;  Yoon, S. -S.;  Shen, Z. X.;  Thein, S. L.;  Lin, K. -H.
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/19


©版权所有 ©2017 CSpace - Powered by CSpace